Alpha-synuclein-induced nigrostriatal degeneration and pramipexole treatment disrupt frontostriatal plasticityNPJ PARKINSONS DISEASEIF8.22024-09-090OAAI
Premorbid performances determine the deleterious effects of nigrostriatal degeneration and pramipexole on behavioural flexibilityNPJ PARKINSONS DISEASEIF8.22023-03-012OAAI
Better Outcomes with Intranigral versus Intrastriatal Cell Transplantation: Relevance for Parkinson's DiseaseCELLSIF5.22022-04-015OAAI
Assessment of Repetitive and Compulsive Behaviors Induced by Pramipexole in Rats: Effect of Alpha-Synuclein-Induced Nigrostriatal DegenerationBIOMEDICINESIF3.92022-02-243OAAI
A metabolic biomarker predicts Parkinson's disease at the early stages in patients and animal modelsJOURNAL OF CLINICAL INVESTIGATIONIF13.62022-02-1512OAAI
Neuropsychiatric and Cognitive Deficits in Parkinson's Disease and Their Modeling in RodentsBIOMEDICINESIF3.92021-06-1722OAAI
Basolateral and central amygdala differentially recruit and maintain dorsolateral striatum-dependent cocaine-seeking habitsNATURE COMMUNICATIONSIF15.72015-12-1478OAAI
Area-Specific Reestablishment of Damaged Circuits in the Adult Cerebral Cortex by Cortical Neurons Derived from Mouse Embryonic Stem CellsNEURONIF152015-03-01119OAAI
Dopamine control of pyramidal neuron activity in the primary motor cortex via D2 receptorsFRONTIERS IN NEURAL CIRCUITSIF32014-01-0143OAAI
Loss of erbB signaling in oligodendrocytes alters myelin and dopaminergic function, a potential mechanism for neuropsychiatric disordersPROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICAIF9.12007-05-08283OAAI
Reduction of cocaine place preference in mice lacking the protein phosphatase 1 inhibitors DARPP 32 or inhibitor 1BIOLOGICAL PSYCHIATRYIF92002-04-0173PRE